Login to your account

Username *
Password *
Remember Me
M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis.

M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis.

The potential benefit of endothelin receptor antagonists’ therapy in idiopathic pulmonary fibrosis: A meta-analysis of results from randomized controlled trials – Medicine  

The post M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis. appeared first on Links Medicus.

Lu 551 fois
Évaluer cet élément
(0 Votes)

About Author

Recherche